On the basis of the above findings, we posited that tumor cell-derived fibulin-2 promotes the migratory, invasive, and proliferative capacity of tumor cells and performed in vitro studies on fibulin-2-deficient cells to test this hypothesis. The gene discussed is FBLN2; the disease is neoplasm.